Cystone®
Composition of each Cystone tablet:
Active ingredients
Em. Didymocarpus pedkeflata 65 mg, Saxifraga ligulata 49 mg, Rubia cordifolia 16 mg, Cyperus scariosus 16 mg, Achyranthes aspera 16 mg, Onosma bracteatum 16 mg, Vernonia cinerea 16 mg. Pdrs. Hajrul yahood bhasma 16 mg, Shilajeet (Purified) 13 mg. Processed in Ocimum basilicum, Dolichos biflorus, Tribulus terrestris, Mimosa pudica, Pavonia odorata, Equisetum arvense,
Tectona grandis seed.
Pharmaceutical form:
Tablets
Pharmacotherapeutic group:
Lithotryptic (disintegrates renal and urinary calculi), Urinary antiseptic.
Mode of action:
Cystone prevents supersaturation of lithogenic substances, controls oxamide (a substance that precipitates stone formation) absorption from the intestine and corrects the crystalloid-colloid imbalance. Cystone inhibits calculogene.sis by
reducing stone forming substances like oxalic acid, calcium hydroxyproline, etc., and causes their expulsion by micropulverization. Cystone causes disintegration of the calculi and the crystals by acting on the mucin, which binds the particles together. Cystone’s antimitrobial activity is beneficial in the prevention of urinary tract infections associated with urinary stones and crystalluria. Cystone’s antispasmodic and anti- inflammatory activities relieve ureteric colic and alleviate symptoms of painful and burning micturition.
Indications :
1- Urolithiasis:
– Oxalate stones.
– Phosphate stones.
– Uric acid and urate stones.
– Crystalluria.
– Prevents post-operative recurrence of calculi.
– Mixed crystals – glycolic acids.
2- As an adjuvant in:
– Urinary tract infections.
– Urinary tract infections during pregnancy.
– Non-specific urethritis.
– Cystitis, pyelitis.
– Burning micturition.
– Gout and hyperuricemia.
3- Urinary incontinence in women.
4- Sialolithiasis.
Contra indications:
No absolute contra indications.
Dosage :
As a curative:
In urolithiasis and crystalluria: 2 tablets thrice daily for 3 to 4 months, followed by 1 tablet twice daily, till stone passes out. In urinary infections: 2 tablets thrice daily depending on the severity of infection, until the infection is cleared.
In burning micturition: 2 tablets thrice daily for 4 days to 2 weeks, or till the symptoms subside. To prevent recurrence after surgical removal or passage: 1 tablet thrice daily for 4 to 5 months.
Route of administration:
Oral
Precautions:
It is advisable not to recommend Cystone in obstructive uropathy due to larger stones.
Adverse effects:
Not reported.
Drug interactions:
Not reported.
Special warnings:
None
Undesirable effects:
Not reported.
Expiry date:
Three years from the date of manufacture. ! .
Storage conditions:
Store in a cool and dry place, away from direct sunlight. Keep out of the reach of children. Do not refrigerate.
Presentation:
Sealed packs of 60 tablets.
Manufactured by:
the himalaya drug Company
